250 related articles for article (PubMed ID: 32287292)
1. Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response.
Alinezhad M; Bakhshandeh M; Rostami E; Alimohamadi R; Mosaffa N; Jalali SA
PLoS One; 2020; 15(4):e0231507. PubMed ID: 32287292
[TBL] [Abstract][Full Text] [Related]
2. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy.
Lan J; Li R; Yin LM; Deng L; Gui J; Chen BQ; Zhou L; Meng MB; Huang QR; Mo XM; Wei YQ; Lu B; Dicker A; Xue JX; Lu Y
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):74-87. PubMed ID: 29619980
[TBL] [Abstract][Full Text] [Related]
3. Abscopal Effects With Hypofractionated Schedules Extending Into the Effector Phase of the Tumor-Specific T-Cell Response.
Zhang X; Niedermann G
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):63-73. PubMed ID: 29534901
[TBL] [Abstract][Full Text] [Related]
4. Postablation Modulation after Single High-Dose Radiation Therapy Improves Tumor Control via Enhanced Immunomodulation.
Savage T; Pandey S; Guha C
Clin Cancer Res; 2020 Feb; 26(4):910-921. PubMed ID: 31757878
[TBL] [Abstract][Full Text] [Related]
5. Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.
Grapin M; Richard C; Limagne E; Boidot R; Morgand V; Bertaut A; Derangere V; Laurent PA; Thibaudin M; Fumet JD; Crehange G; Ghiringhelli F; Mirjolet C
J Immunother Cancer; 2019 Jun; 7(1):160. PubMed ID: 31238970
[TBL] [Abstract][Full Text] [Related]
6. Radiation dose and schedule influence the abscopal effect in a bilateral murine CT26 tumor model.
Ghaffari-Nazari H; Alimohammadi M; Alimohammadi R; Rostami E; Bakhshandeh M; Webster TJ; Mahmoodi Chalbatani G; Tavakkol-Afshari J; Amir Jalali S
Int Immunopharmacol; 2022 Jul; 108():108737. PubMed ID: 35417831
[TBL] [Abstract][Full Text] [Related]
7. Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1.
Park JH; Kim HY; Lee A; Seo YK; Kim IH; Park ET; Kang MS; Park SJ; Park S
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):510-520. PubMed ID: 33383126
[TBL] [Abstract][Full Text] [Related]
8. Combined α-programmed death-1 monoclonal antibody blockade and fractionated radiation therapy reduces tumor growth in mouse EL4 lymphoma.
Lin X; Zeng T; Xiong J; Zhang Q; Jiang P; Li X; Lin S; Xu Q; Weng H; Lai H; Gong H; Lin J; Cheng N; Tian X; Xu Y; Fang S; Jin R; Chen Z; Yang J; Morton L; Yueh B; Lin J
Cancer Biol Ther; 2019; 20(5):666-679. PubMed ID: 30572778
[TBL] [Abstract][Full Text] [Related]
9. Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions.
Filatenkov A; Baker J; Mueller AM; Kenkel J; Ahn GO; Dutt S; Zhang N; Kohrt H; Jensen K; Dejbakhsh-Jones S; Shizuru JA; Negrin RN; Engleman EG; Strober S
Clin Cancer Res; 2015 Aug; 21(16):3727-39. PubMed ID: 25869387
[TBL] [Abstract][Full Text] [Related]
10. In Vitro Radiobiological Advantages of Hypofractionation Compared with Conventional Fractionation: Early-Passage NSCLC Cells are Less Aggressive after Hypofractionation.
Zhang H; Wan C; Huang J; Yang C; Qin Y; Lu Y; Ma J; Wu B; Xu S; Wu G; Yang K
Radiat Res; 2018 Dec; 190(6):584-595. PubMed ID: 30234458
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Molecular-level Changes of Programmed Cell Death Ligand-1 after Radiation Therapy in a BALB/c CT26 Colorectal Mouse Tumor Model.
Khani Chamani F; Shabani M; Moradi A; Alinejad M; Jalali SA
Iran J Allergy Asthma Immunol; 2023 Apr; 22(2):163-171. PubMed ID: 37496409
[TBL] [Abstract][Full Text] [Related]
12. Differential Immune Modulation With Carbon-Ion Versus Photon Therapy.
Spina CS; Tsuruoka C; Mao W; Sunaoshi MM; Chaimowitz M; Shang Y; Welch D; Wang YF; Venturini N; Kakinuma S; Drake CG
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):813-818. PubMed ID: 33190969
[TBL] [Abstract][Full Text] [Related]
13. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers.
Mohan R; Wu Q; Manning M; Schmidt-Ullrich R
Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):619-30. PubMed ID: 10701741
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Total Body Irradiation Can Enhance Systemic Immune Related Response Induced by Hypo-Fractionated Radiation.
Liu J; Zhou J; Wu M; Hu C; Yang J; Li D; Wu P; Chen Y; Chen P; Lin S; Cui Y; Fu S; Wu J
Front Immunol; 2019; 10():317. PubMed ID: 30873170
[TBL] [Abstract][Full Text] [Related]
15. Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary Intervention.
Omene C; Ma L; Moore J; Ouyang H; Illa-Bochaca I; Chou W; Patel MS; Sebastiano C; Demaria S; Mao JH; Karagoz K; Gatza ML; Barcellos-Hoff MH
Cancer Immunol Res; 2020 Feb; 8(2):217-229. PubMed ID: 31831632
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and Albumin-Based Gold-Cisplatin Nanoparticles Enhance Ablative Radiation Therapy-Induced Antitumor Immunity in Local and Distant Tumor Microenvironment.
Chen JL; Yang SJ; Pan CK; Lin LC; Tsai CY; Wang CH; Huang YS; Lin YL; Kuo SH; Shieh MJ
Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1135-1149. PubMed ID: 36792014
[TBL] [Abstract][Full Text] [Related]
17. SMAC Mimetic Debio 1143 and Ablative Radiation Therapy Synergize to Enhance Antitumor Immunity against Lung Cancer.
Tao Z; McCall NS; Wiedemann N; Vuagniaux G; Yuan Z; Lu B
Clin Cancer Res; 2019 Feb; 25(3):1113-1124. PubMed ID: 30352911
[TBL] [Abstract][Full Text] [Related]
18. Combination treatment with hypofractionated radiotherapy plus IL-2/anti-IL-2 complexes and its theranostic evaluation.
Jing H; Hettich M; Gaedicke S; Firat E; Bartholomä M; Niedermann G
J Immunother Cancer; 2019 Feb; 7(1):55. PubMed ID: 30808414
[TBL] [Abstract][Full Text] [Related]
19. Combination low-dose cyclophosphamide with check-point blockade and ionizing radiation promote an abscopal effect in mouse models of melanoma.
Luo X; Zeng M
J Cancer Res Ther; 2024 Apr; 20(2):718-725. PubMed ID: 38687945
[TBL] [Abstract][Full Text] [Related]
20. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
Shibamoto Y; Miyakawa A; Otsuka S; Iwata H
J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i76-i82. PubMed ID: 27006380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
